Work

Mechanisms of CD40-dependent cDC1 licensing beyond costimulation

Year: 2022

Type: article

Source: Nature Immunology

DOI: 10.1038/s41590-022-01324-w

Authors: Renee Wu, Ray A. Ohara, Suin Jo, Tian-Tian Liu, Stephen T. Ferris, Feiya Ou, Sunkyung Kim, Derek J. Theisen, David A. Anderson, Brian W. Wong, Timothy Gershon, Robert D. Schreiber, Theresa L. Murphy, Kenneth M. Murphy

Institutions: Washington University in St. Louis, University of North Carolina at Chapel Hill, Emory University, Parker Institute for Cancer Immunotherapy

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1372751485, G1927151046, G1938931754, G232890196, G2337220457, G2452401729, G2550111360, G2603676410, G2953113384, Differentiation/migratory fate of monocyte-derived cells, G4103495802, Function of Wdfy4 in cross-presentation and immunity, Mechanism of c-MYC repression by IRF8 in myeloid lineages, G4958605441, Mechanism of c-MYC repression by IRF8 in myeloid lineages, G549588668, G5643898109, The role of type 1 dendritic cells in CD4 and CD8 T cell anti-tumor immunity, G679120464, G6878217091, G6909035093, Function of Wdfy4 in cross-presentation and immunity, Transcriptional basis of embryonic macrophage development, DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY, G8685603942, G8808132624, Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming, TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER, Molecular Basis of cDC1 Development, Cancer Center Support Grant

OpenAlex ID: W4307040711

FWCI: 4.279

Cites: 77

Cited by: 75

Related to: 10